What happened next may become the most important medical story of the decade. In just six months, a team at Children’s ...

The ACC issued new guidance for managing common pediatric left-to-right shunts, including ASD, VSD, and PDA, in the ...

Specific FBN1 variants are associated with an increased risk for severe mitral regurgitation and surgery in Marfan syndrome.

HOUSTON, TX, UNITED STATES, April 7, 2026 /EINPresswire.com/ -- HeartLung AI today welcomed CMS’s establishment of ...

The researchers identified a driving force behind the condition, opening up a potential target for new therapies.

Background Marfan syndrome (MFS) is a multisystemic disorder caused by pathogenic (P) variants in the fibrillin-1 gene ( FBN1 ...

Medtronic (NYSE:MDT) today announced data from the ALERT trial aimed at addressing health disparities in structural heart care.

New cholesterol guidelines aim to make heart prevention simpler and more personal. On March 13, the American College of Cardiology and American Heart Association released updated recommendations, ...

Lipoprotein(a) is a genetically inherited cholesterol particle that significantly increases the risk of premature cardiovascular disease. Unlike regular LDL cholesterol, Lp(a) levels are determined at ...

A blood test clarifies which gene variants truly cause congenital heart defects, linking diagnosis to more precise heart‑signal–targeted treatments.

Among asymptomatic patients with severe aortic stenosis, a previous analysis showed that the risk of a composite of death during surgery or within 30 days after surgery (called operative mortality) or ...

The US Food and Drug Administration has approved the Trilogy transcatheter heart valve (JenaValve) for patients with symptomatic severe aortic regurgitation at high risk for surgery, according to an ...